단삼이 당뇨병성 신병증 Rat의 신기능 및 조직학적 변화에 미치는 영향
The Effects of Salvia Miltiorrhiza on Renal Function and Histopathological Changes in Streptozotocin-induced Diabetic Nephropathy Rat Model
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objective : Diabetic nephropathy is the most common cause of end stage renal disease. AGE, TGF-β1, type Ⅳ collagen, and macrophage/monocyte infiltration are the main factors of diabetic nephropathy. We investigated the effects of Salvia miltiorrhiza on renal function and histopathological changes in streptozotocin(STZ)-induced diabetic nephropathy rat model. Methods : Diabetes was induced in male Sprague-Dawley rats(290±10g) by injecting STZ(45㎎/㎏) into the tail vein. Rats were divided into 3 groups(n=6): normal, control, and salvia. After 8 weeks of administration of Salvia miltiorrhiza extract on the Salvia group, we checked 24 hrs urine, blood biochemistry and renal tissue to evaluate renal function and histopathological changes by examining parameters including albuminuria, BUN, creatinine, cholesterol, LDL, TG, macrophage/monocyte antigen(ED-1), TGF-β1, AGE, and type Ⅳ collagen. Results : Salvia miltiorrhiza decreased the amount of 24hrs proteinuria, and inhibited histopathological changes of diabetic nephropathy including the expression and accumulation of various factors which could promote development of diabetic nephropathy. Conclusion : These findings suggest that Salvia miltiorrhiza might protect the renal function and inhibit the development of renal injury by regulating factors including AGE, TGF-β1, Type Ⅳ collagen, macrophage and monocyte infiltration. So Salvia miltiorrhiza can be used for diabetic patients to prevent the progression of diabetic nephropathy.
Abstract
Objective : Diabetic nephropathy is the most common cause of end stage renal disease. AGE, TGF-β1, type Ⅳ collagen, and macrophage/monocyte infiltration are the main factors of diabetic nephropathy. We investigated the effects of Salvia miltiorrhiza on renal function and histopathological changes in streptozotocin(STZ)-induced diabetic nephropathy rat model. Methods : Diabetes was induced in male Sprague-Dawley rats(290±10g) by injecting STZ(45㎎/㎏) into the tail vein. Rats were divided into 3 groups(n=6): normal, control, and salvia. After 8 weeks of administration of Salvia miltiorrhiza extract on the Salvia group, we checked 24 hrs urine, blood biochemistry and renal tissue to evaluate renal function and histopathological changes by examining parameters including albuminuria, BUN, creatinine, cholesterol, LDL, TG, macrophage/monocyte antigen(ED-1), TGF-β1, AGE, and type Ⅳ collagen. Results : Salvia miltiorrhiza decreased the amount of 24hrs proteinuria, and inhibited histopathological changes of diabetic nephropathy including the expression and accumulation of various factors which could promote development of diabetic nephropathy. Conclusion : These findings suggest that Salvia miltiorrhiza might protect the renal function and inhibit the development of renal injury by regulating factors including AGE, TGF-β1, Type Ⅳ collagen, macrophage and monocyte infiltration. So Salvia miltiorrhiza can be used for diabetic patients to prevent the progression of diabetic nephropathy.
참고문헌 (30)
- 최영길, "당뇨병성 혈관합병증 진단과 치료", pp.3~7 (1998), 의학
- 김용진, "당뇨병학", pp.471~486 (2005), 대한당뇨병학회
- 임상신장학, "대한신장학회", pp.321~345 (2001), 광문출판사
- Ralph Rabkin, "Diabetic Nephropathy, Complications of Diabetes", Clinical Cornerstone, 5;2, pp.1~11 (2003)
- T.A. Chowdhury, "Pathogenesis of Diabetic Nephropathy", Trends Endocrinol Metab, 7;9, pp.320~323 (1996)
- Mark E. Cooper, "Pathophysiology of Diabetic Nephropathy", Metabolism, 47;12, pp.3~6 (1998)
- Michael Wei, "The Streptozotocin - Diabetic Rat as a Model of the Chronic Complications of Human Diabetes", Heart Lung and Circulation, 12, pp.44~50 (2003)
- 안세영, "東醫臨床內科學 Ⅱ", pp.80~93 (1999), 법인문화사
- 김성아, "당뇨병성 신증의 한의학적 접근 및 치료에 대한 연구", 대한한의정보학회지, 11(2), pp.1~13 (2005)
- 두호경, "동의신계학", pp.389~391 (1993), 동양의학연구원
- 본초학교실, "본초학", pp.419~420 (1992), 영림사
- Kevin K.M. Yue, "Danshen prevents the occurrence of oxidative stress in the eye and aorta of diabetic rats without affecting the hyperglycemic state", Journal of Ethnopharmacology, 106, pp.136~141 (2006)
- Geun Taek Lee, "Delayed Treatment with lithospermate B attenuates Experimental Diabetic Renal Injury", Journal of American Society of Nephrology, 14, pp.709~720 (2003)
- E.P.K. Mensah-Brown, "Streptozotocin-induced diabetic nephropathy in rats: The role of inflammatory cytokines", Cytokine, 31, pp.180~190 (2005)
- 안영민, "한방으로 이겨내는 당뇨병", pp.146~151 (2003), 홍신문화사
- Takako Yokozawa, "Animal model of diabetic nephropathy", Exp Toxic Pathol, 53, pp.359~363 (2001)
- Rainer Lehmann, "Molecular mechanism of diabetic nephropathy", nica Chimica Acta, 297, pp.135~144 (2000)
- Abbas, Lichtman, "세포 분자 면역학", pp.16~39 (1998), 범문사
- Dick de Zeeuw, "Should Albuminuria Be a Therapeutic Target in Patients With Hypertension and Diabetes?", American Journal of Hypertension, 17, pp.11~15 (2004)
- Giuseppe Remuzzi, "Albuminuria as early test for vascular disease", Lancet, 365, pp.556~567 (2005)
- Marcello Casaccia Bertoluci, "Fa´bio Ramos Oliveira. Urinary TGF-β1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy", Diabetes Research and Clinical Practice, 72, pp.258~264 (2006)
- Ching Ye Hong, "Markers of Diabetic Nephropathy", Journal of Diabetes and its Complications, 12, pp.43~60 (1998)
- Nobuo Kotajima, "Type Ⅳ collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus", Journal of Diabetes and its Complications, 14, pp.13~17 (2000)
- Michel Zeisberg, "Differential expression of type Ⅳ collagen isoforms in rat glomerular endothelial and mesangial cells", Biochemical and Biophysical Research Communications, 295, pp.401~407 (2002)
- Seijiro Kado, "Urinary type Ⅳ collagen as a marker for early diabetic nephropathy", Diabetes Research and Clinical Practice, 31, pp.103~108 (1996)
- Elena Gagliardini, "Role of anti-TGF-β antibodies in the treatment of renal injury", Cytokine & Growth Factor Reviews, 17, pp.89~96 (2006)
- Mary H. Branton, "TGF-β and fibrosis", Microbes and Infection, 1, pp.1349~1365 (1999)
- Joseph Cantor1, "Interactions of macrophages and T cells in autoimmune diabetes", Drug Discovery Today, 30, pp.20~1 (2006), 5
- Tomoko Shimoike, "The Meaning of Serum Levels of Advanced Glycosylation End Products in Diabetic Nephropathy", Metabolism, 49, pp.1030~1035 (2000)
- Yasuhiko Yamamoto, "The role of AGE–RAGE system in the development of diabetic nephropathy in vivo", International Congress Series, 1245, pp.45~50 (2002)